Back to Journals » Infection and Drug Resistance
Infection and Drug Resistance
Editor-in-Chief: Dr Oliver Planz
An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal, viral and parasitic) and the development and institution of preventative strategies to minimize the development and spread of resistance.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (4972)
- Volume 19, 2026 (414)
- Volume 18, 2025 (601)
- Volume 17, 2024 (563)
- Volume 16, 2023 (705)
- Volume 15, 2022 (735)
- Volume 14, 2021 (553)
- Volume 13, 2020 (470)
- Volume 12, 2019 (399)
- Volume 11, 2018 (262)
- Volume 10, 2017 (60)
- Volume 9, 2016 (34)
- Volume 8, 2015 (39)
- Volume 7, 2014 (38)
- Volume 6, 2013 (25)
- Volume 5, 2012 (20)
- Volume 4, 2011 (23)
- Volume 3, 2010 (16)
- Volume 2, 2009 (5)
- Volume 1, 2008 (10)
Latest articles:
- 5 records -
Real-World Clinical Outcomes of Sulbactam-Durlobactam Against Carbapenem-Resistant Acinetobacter baumannii with Diverse β-Lactamase Profiles: A Multicenter Study in China
Liu C, Chen Y, Wang L, Wang J, Xu D, Chen Z, Shu C, He Y
Infection and Drug Resistance 2026, 19:614543
Published Date: 23 July 2026
Risk Stratification for Vancomycin-Associated Acute Kidney Injury in Chinese Adult Inpatients: A Multicenter Retrospective Cohort Study
Chen S, Zhang Y, Hou X, Wang Y, Zuo C, Huang C, Xia X, Cao C, Lv Q, Li X, Pan K
Infection and Drug Resistance 2026, 19:618586
Published Date: 22 July 2026
Analysis of Risk Factors for High versus Low HIV Exposure in Neonates and Development of a Predictive Nomogram Model
Li L, Lin J, Huang X, Pan M
Infection and Drug Resistance 2026, 19:619029
Published Date: 22 July 2026
Access to Reserve Antibiotics in Latin America and the Caribbean: Situation, Challenges, and Future Directions
Ribeiro S, Nuccetelli Y, Cornistein W, Staneloni MI
Infection and Drug Resistance 2026, 19:547524
Published Date: 22 July 2026
The Outcome of Tuberculosis Treatment in the Presence of SARS-CoV-2 Anti-RBD Antibody
Muflihah H, Yulianto FA, Maharani W, Hanipan AR
Infection and Drug Resistance 2026, 19:579272
Published Date: 21 July 2026